Metallome of sclerotic hippocampi in patients with drug-resistant mesial temporal lobe epilepsy by Ristic, A. J. et al.
p583
METALLOMEOF SCLEROTICHIPPOCAMPI IN
PATIENTSWITHDRUG-RESISTANTMESIAL
TEMPORAL LOBEEPILEPSY
Ristić AJ1, Sokic D1, Bascarevic V2, Spasic S3, Vojvodic N1,
Savic S4, Raicevic S2, Kovacevic M1, Savic D5, Spasojevic I6
1Epilepsy Center, Neurology Clinic, Clinical Center of Serbia,
Belgrade, Serbia, 2Neurosurgery Clinic, Clinical Center of
Serbia, Belgrade, Serbia, 3Department of Chemistry, Institute of
Chemistry, Technology, andMetallurgy, University of Belgrade,
Belgrade, Serbia, 4Institute of Forensic Medicine, Medical
School, University of Belgrade, Belgrade, Serbia, 5Department
of Neurobiology, Institute for Biological Research “Sinisa
Stankovic”, University of Belgrade, Belgrade, Serbia, 6Life
Sciences Department, Institute for Multidisciplinary Research,
University of Belgrade, Belgrade, Serbia
Purpose: Altered hippocampal metallome is strongly implicated in the
pathology of mesial temporal lobe epilepsy with hippocampal sclerosis
(mTLE-HS). We aimed to determine sodium, potassium, calcium, mag-
nesium, iron, copper, manganese, and zinc concentration in epileptic
human hippocampi.
Method: Hippocampi of 24 drug-resistant mTLE-HS patients (age:
35.6  9.4 years) that underwent anterior temporal lobe resection and
amygdalohippocampectomy surgery, and 17 hippocampi obtained by
autopsy from 13 controls (age: 40.5  12.9 years) were analyzed using
inductively coupled plasma optical emission spectrometry.
Results: Epileptic hippocampi showed significantly lower concentra-
tions (lg/g of tissue) of copper (HS: 2.34  0.12; control (C):
3.57  0.33; p < 0.001), manganese (HS: 0.205  0.030; C:
0.409  0.064; p = 0.004), and potassium (HS: 2001  59; C:
2322  61; p < 0.001), and increased sodium level (HS: 1131  22; C:
1040  25; p = 0.010). Zinc concentration was slightly higher in HS
(13.97  1.51 lg/g) compared to controls (10.97  1.03 lg/g),
whereas iron, calcium, and magnesium levels did not differ.
Conclusion: Our results provide a relevant prerequisite for understand-
ing the potential involvement of different metals in the pathology of HS,
emphasizing general deregulation of metallome, copper and manganese
deficiency, and the absence of iron accumulation.
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Purpose: Epilepsy has been associated with cerebral white matter tract
abnormalities. Retinal nerve fiber layer thickness is related to the axonal
anterior visual pathway and is considered a marker of overall white mat-
ter “integrity”. Retinal nerve fiber layer thickness was previously
assessed in a cohort of people with epilepsy and a history of vigabatrin
exposure, showing significant thinning compared to healthy controls. We
hypothesised that retinal nerve fiber layer changes would occur in people
with chronic epilepsy, independently of previous vigabatrin treatment,
related to clinical characteristics of epilepsy.
Method: Three hundred subjects with chronic epilepsy and 90 healthy
controls were included. People with previous exposure to vigabatrin or
known ocular disease were excluded from the analysis. Retinal nerve
fiber layer imaging was performed using spectral-domain Optical Coher-
ence Tomography.
Results: People with epilepsy had significantly lower average retinal
nerve fiber layer thickness and lower thickness of each of the 90°
quadrants than healthy controls (p < 0.001, Wilcoxon rank-sum test).
In a multivariate logistic regression model, drug resistance was the
only significant predictor of abnormal retinal nerve fiber layer thinning
(OR 2.09, CI 95% 1.09–4.01, p = 0.03). Duration of epilepsy and the
presence of intellectual disability also showed a significant relationship
with retinal nerve fiber layer thinning in a multivariate linear regres-
sion model (coefficients 0.16, p = 0.004 and 4.0, p = 0.044,
respectively).
Conclusion: This suggests that drug-resistant epilepsy is associated with
thinning of the retinal nerve fiber layer. As this is easily assessed by opti-
cal coherence tomography, retinal nerve fiber layer thickness is a candi-
date biomarker of drug resistance and, by extension, of epilepsy severity.
Longitudinal studies are now needed. The underlying mechanisms are
unknown and may be diverse.
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Purpose: Epilepsy is a chronic neurological disorder, characterized by
recurrent seizures occurring as a result of synchronized discharges of
neurons in brain. As 33% of patients develop resistance against therapy
while others are not without side effects, therefore, need for better and
safer drugs is crucial. Neurtrophic factors and Oxidative stress are emerg-
ing as mechanisms that may play an important role in the etiology of sei-
zure-induced neuronal death. In the present study, Aconitum cochleare
WOROSCHIN-oil (ACR-oil) was tested for its ability (i) to suppress the
convulsive and lethal effects of Pentylenetetrazole (PTZ) in kindled
mice, (ii) to attenuate the PTZ-induced oxidative injury in the brain tissue
and (iii) to modulate the gene expression BDNF and its receptor Trk-B
when given as a pretreatment prior to each PTZ injection during kindling
acquisition. Diazepam and valproic acid, major antiepileptic drugs, were
also tested for comparison.
Methods: Once acute screening was done, all groups except for control
group were kindled by injections of PTZ with an interval of 48 h
(n = 12). In the 18th injection, all groups were sacrificed and the brain
samples were collected and used for determination of oxidative stress
parameters and targeted gene expressions by PCR.
Results: Our results suggest that ACR-oil treatment (100 mg/kg,
200 mg/kg) significantly inhibit, both acute and chronic PTZ induced
seizures (p < 0.05). Toxicity studies demonstrate that the test oil is
devoid of major toxic effects on suggested doses. Our test oil not only
produced antiepileptic effect but also diminished the PTZ induced oxida-
tive stress (p < 0.05, p < 0.001).
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